RFK Jr. readies review of childhood vaccine schedule after pledging not to

Zachary Brennan

Senior Editor

In his first speech to staff as newly-confirmed HHS secretary, Robert F. Kennedy Jr. said Tuesday that he will review the childhood vaccine schedule despite …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

RFK Jr. readies review of childhood vaccine schedule after pledging not to

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Kennedy announces 10,000 job cuts at HHS, with major reductions expected at FDA, NIH and CDC

FDA approves first drug for Prader-Willi syndrome, to tamp down insatiable hunger symptoms

Aurion CEO is out as Alcon takes majority stake in cell therapy startup

Small biotech joins list of health companies taking a trip to Trump's Mar-a-Lago

Candel to focus on non-squamous lung cancer following new survival data

Galatea Bio gets $25M to map genetic diversity of 10 million people, help pharma create new medicines

RFK Jr. read­ies re­view of child­hood vac­cine sched­ule af­ter pledg­ing not to

Zachary Brennan

Senior Editor

Sign up to read this article for free.

more like this

Kennedy an­nounces 10,000 job cuts at HHS, with ma­jor re­duc­tions ex­pect­ed at FDA, NIH and CDC

FDA ap­proves first drug for Prad­er-Willi syn­drome, to tamp down in­sa­tiable hunger symp­toms

Au­ri­on CEO is out as Al­con takes ma­jor­i­ty stake in cell ther­a­py start­up

Small biotech joins list of health com­pa­nies tak­ing a trip to Trump's Mar-a-La­go

Can­del to fo­cus on non-squa­mous lung can­cer fol­low­ing new sur­vival da­ta

Galatea Bio gets $25M to map ge­net­ic di­ver­si­ty of 10 mil­lion peo­ple, help phar­ma cre­ate new med­i­cines

RFK Jr. readies review of childhood vaccine schedule after pledging not to

Kennedy announces 10,000 job cuts at HHS, with major reductions expected at FDA, NIH and CDC

FDA approves first drug for Prader-Willi syndrome, to tamp down insatiable hunger symptoms

Aurion CEO is out as Alcon takes majority stake in cell therapy startup

Small biotech joins list of health companies taking a trip to Trump's Mar-a-Lago

Candel to focus on non-squamous lung cancer following new survival data

Galatea Bio gets $25M to map genetic diversity of 10 million people, help pharma create new medicines